read the company's respond to the ACA programme. seems that ACA made a mistake as the product contains the enzymes for it work which was missed by the 'experts'
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025